Clarification on China agencies’ redundancy reduction effort
This article was originally published in The Gray Sheet
Executive Summary
Plan for China's Administration of Quality Supervision, Inspection and Quarantine and its State Food and Drug Administration to reduce redundancies between them by requiring only one test, one report, one fee and one factory inspection, applies to eight specific device types (1"The Gray Sheet" Sept. 22, 2008, p. 8). Other device types were not affected by the problem. The eight types include: X-ray systems, hemodialysis systems, extracorporeal circulation tubes for blood purification, hollow-fiber dialyzers, heart-lung machines, electrocardiographs, pacemakers and condoms
You may also be interested in...
Chinese Agencies’ Agreement Could Halve Approval Time For U.S. Devices
Chinese approval time for imported medical devices could be cut in half under an agreement to reduce redundancies between the country's Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) and its State Food and Drug Administration (SFDA)
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.